Carli M, Prontera C, Samanin R
Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
Neuropharmacology. 1989 May;28(5):471-6. doi: 10.1016/0028-3908(89)90081-6.
Deficits in locomotion and exploratory behaviour in an open field were induced in rats by restraint for 2 hr, 23 hr before testing. Diazepam, 0.62 and 1.25 mg/kg, intraperitoneally (i.p.), 15 min before testing, reversed the stress-induced reduction in locomotion; 1.25 mg/kg also attenuated the effect of stress on exploration (rearing and object exploring). Diazepam did not affect the activity of controls. A putative anxiogenic compound, pyrazoloquinoline (CGS 8216, 10 mg/kg administered 30 min before testing), also markedly reduced locomotion and exploration and the effect was reversed by 2.5 mg/kg diazepam, 15 min before testing. Buspirone, 0.1 mg/kg subcutaneously (s.c.) 15 min before testing, significantly attenuated the effect of stress on locomotion and exploration but had no effect in controls. Larger doses (0.5 and 1.0 mg/kg) markedly reduced the behavioural measures in controls and did not modify or enhance the effect of stress. 8-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), 0.25 and 0.5 mg/kg (s.c.), 1 hr before testing, significantly attenuated the reduction in locomotion without affecting rearing and object-exploring in stressed rats. At doses from 0.125 to 0.5 mg/kg, 8-OH-DPAT reduced exploration in control rats. Two hr after restraint (corresponding to 21 hr before testing in the open field) 8-OH-DPAT, 0.125 to 2 mg/kg (s.c.), did not modify the open field deficits, caused by stress. In these treatment conditions, 0.5 and 2 mg/kg 8-OH-DPAT reduced locomotion and exploration in control rats.(ABSTRACT TRUNCATED AT 250 WORDS)
在测试前23小时对大鼠进行2小时的束缚,可诱发其在旷场中的运动和探索行为缺陷。在测试前15分钟腹腔注射(i.p.)0.62和1.25毫克/千克的地西泮,可逆转应激诱导的运动减少;1.25毫克/千克的地西泮还可减弱应激对探索行为(竖毛和物体探索)的影响。地西泮不影响对照组的活动。一种假定的致焦虑化合物吡唑并喹啉(CGS 8216,在测试前30分钟给予10毫克/千克)也显著降低了运动和探索行为,且在测试前15分钟给予2.5毫克/千克的地西泮可逆转该效应。在测试前15分钟皮下注射(s.c.)0.1毫克/千克的丁螺环酮,可显著减弱应激对运动和探索行为的影响,但对对照组无影响。更大剂量(0.5和1.0毫克/千克)可显著降低对照组的行为指标,且未改变或增强应激的影响。在测试前1小时皮下注射0.25和0.5毫克/千克的8-羟基-2-(二正丙基氨基)四氢萘(8-OH-DPAT),可显著减弱应激大鼠运动的减少,且不影响竖毛和物体探索行为。在0.125至0.5毫克/千克的剂量下,8-OH-DPAT可减少对照组大鼠的探索行为。束缚2小时后(相当于在旷场测试前21小时),0.125至2毫克/千克(s.c.)的8-OH-DPAT未改变应激引起的旷场缺陷。在这些治疗条件下,0.5和2毫克/千克的8-OH-DPAT可减少对照组大鼠的运动和探索行为。(摘要截短至250字)